MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells

Medical Oncology

Volumn 31, Issue 1, 2014, Pages

  Luo, Hua Nan ^a   Wang, Zheng Hui ^a   Sheng, Ying ^a   Zhang, Qing ^a   Yan, Jing ^a   Hou, Jin ^a   Zhu, Kang ^a   Cheng, Ying ^a   Xu, Ying Long ^a   Zhang, Xiang Hong ^a   Xu, Min ^a   Ren, Xiao Yong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

CXCR4; Laryngeal squamous carcinoma cell; Metastasis; MicroRNA; Proliferation

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MICRORNA; MICRORNA 139; MICRORNA 9; UNCLASSIFIED DRUG; CXCR4 PROTEIN, HUMAN; MIRN139 MICRORNA, HUMAN;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CARCINOMA CELL; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CARCINOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEK293 CELL LINE; LARYNX TUMOR; MALE; METABOLISM; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RECEPTORS, CXCR4;

MLCS; MLOWN;

EID: 84889004092     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0789-z     Document Type: Article

References (33)

1. Zheng X, Xie Q, Li S, et al. CXCR4-positive subset of glioma is enriched for cancer stem cells. Oncol Res. 2011;19:555-61.
2. Zhang SS, Han ZP, Jing YY, et al. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med. 2012;10:85.
3. Luo G, Long J, Cui X, et al. Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties. Int J Oncol. 2013;42:979-84.
4. Corry J, Peters L, Kleid S, et al. Larynx preservation for patients with locally advanced laryngeal cancer. J Clin Oncol. 2013;31:840-4.
5. Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet. 2006;38:1060-5. (Pubitemid 44325933)
6. Fareh M, Turchi L, Virolle V, et al. The miR302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differ. 2012;19:232-44.
7. Lewis BP, Shih IH, Jones-Rhoades MW, et al. Prediction of mammalian microRNA targets. Cell. 2003;115:787-98. (Pubitemid 38058492)
8. Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37:495-500. (Pubitemid 40617277)
9. Griffiths-Jones S, Saini HK, van Dongen S, et al. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008;36:D154-8. (Pubitemid 351149713)
10. Ou DL, Chen CL, Lin SB, et al. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. J Pathol. 2006;210:363-73. (Pubitemid 44660516)
11. Jorgensen S, Baker A, Moller S, et al. Robust 1-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods. 2010;52:375-81.
12. Segura MF, Hanniford D, Menendez S, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci. 2009;106:1814-9.
13. Wang Z, Ma Q, Liu Q, et al. Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer. Br J Cancer. 2008;99:1695-703.
14. Tiscornia G, Singer O, Verma IM. Production and purification of lentiviral vectors. Nat Protoc. 2006;1:241-5.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-8. (Pubitemid 34164012)
16. Cai Y, Yang Y, Shen M, et al. Inhibition of cytokinesis by overexpression of NudCL that is localized to the centrosome and midbody. Cell Res. 2009;19:1305-8.
17. Tsang WP, Kwok TT. The miR-18a*microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis. 2009;30:953-9.
18. Martinho O, Pinto F, Granja S, et al. RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy. PLoSOne. 2013;8:e59104.
19. Li XP, Li CY, Li X, et al. Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus-mediated expression of human endostatin. Mol Cancer Ther. 2006;5:1290-8. (Pubitemid 43881322)
20. Skalsky RL, Cullen BR. Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PLoS ONE. 2011;6:e24248.
21. Wong CC, Wong CM, Tung EK, et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology. 2011;140:322-31.
22. Li RY, Chen LC, Zhang HY, et al. MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma. CNS Neurosci Ther. 2013;19:477-83.
23. Chang KH, Miller N, Kheirelseid EA, et al. MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis. 2011;26:1415-22.
24. Lin M, Chen W, Huang J, et al. MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol Rep. 2011;25:739-47.
25. Cheng L, Huang Z, Zhou W, et al. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell. 2013;153:139-52.
26. Faber A, Hoermann K, Stern-Straeter J, et al. Functional effects of SDF-1α on a CD44(+) CXCR4(+) squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche. Oncol Rep. 2013;29:579-84.
27. Tan CT, Chu CY, Lu YC, et al. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. Carcinogenesis. 2008;29:1519-27.
28. Li KC, Huang YH, Ho CY, et al. The role of IL-8 in the SDF-1α/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma. Oral Oncol. 2012;48:507-15.
29. Labbaye C, Spinello I, Quaranta MT, et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol. 2008;10:788-801. (Pubitemid 351927708)
30. Punj V, Matta H, Schamus S, et al. Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein(vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a. Oncogene. 2010;29:1835-44.
31. Tano N, Kim HW. Ashraf M.microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting CXCR4. PLoS ONE. 2011;6:e23114.
32. Bao W, Fu HJ, Xie QS, et al. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology. 2011;141:2076-87.
33. Leone V, D'Angelo D, Rubio I, et al. MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha. J Clin Endocrinol Metab. 2011;96:E1388-98.